Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prevalence of Antibodies to SARS-CoV-2 in Italian Adults and Associated Risk Factors
Antonio Vena, Marco Berruti, Andrea Adessi, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 9, pp. 2780-2780
Open Access | Times Cited: 76

Showing 26-50 of 76 citing articles:

The effect of laboratory-verified smoking on SARS-CoV-2 infection: results from the Troina sero-epidemiological survey
Venera Tomaselli, Pietro Ferrara, Giulio Giacomo Cantone, et al.
Internal and Emergency Medicine (2022) Vol. 17, Iss. 6, pp. 1617-1630
Open Access | Times Cited: 13
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study
Antonio Vena, Lucia Taramasso, Antonio Di Biagio, et al.
Infectious Diseases and Therapy (2021) Vol. 10, Iss. 1, pp. 387-398
Open Access | Times Cited: 17
Seroprevalence of anti-SARS-CoV-2 antibodies in the Northern Italy population before the COVID-19 second wave
Nausicaa Berselli, Tommaso Filippini, Stefania Paduano, et al.
International Journal of Occupational Medicine and Environmental Health (2021) Vol. 35, Iss. 1, pp. 63-74
Open Access | Times Cited: 16
Seroprevalence and SARS-CoV-2 invasion in general populations: A scoping review over the first year of the pandemic
Clémentine Metzger, Taylor Leroy, Agathe Bochnakian, et al.
PLoS ONE (2023) Vol. 18, Iss. 4, pp. e0269104-e0269104
Open Access | Times Cited: 5
Seroprevalence of SARS-CoV-2 IgG Antibodies in Corsica (France), April and June 2020
Lisandru Capai, Nazlı Ayhan, Shirley Masse, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 11, pp. 3569-3569
Open Access | Times Cited: 14
Seroprevalence of Anti-SARS-CoV-2 IgG and IgM among Adults over 65 Years Old in the South of Italy
Immacolata Polvere, Alfredina Parrella, Giovanna Casamassa, et al.
Diagnostics (2021) Vol. 11, Iss. 3, pp. 483-483
Open Access | Times Cited: 13
Serological surveillance reveals a high exposure to SARS-CoV-2 and altered immune response among COVID-19 unvaccinated Cameroonian individuals
Arlette Flore Moguem Soubgui, Wilfred Steve Ndeme Mboussi, Loick Pradel Kojom Foko, et al.
PLOS Global Public Health (2024) Vol. 4, Iss. 2, pp. e0002380-e0002380
Open Access | Times Cited: 1
Time-varying risk of death after SARS-CoV-2 infection in Swedish long-term care facility residents: a matched cohort study
Marcel Ballin, John P. A. Ioannidis, Jonathan Bergman, et al.
BMJ Open (2022) Vol. 12, Iss. 11, pp. e066258-e066258
Open Access | Times Cited: 8
Seroprevalence of antibodies against SARS-CoV-2 virus in Northern Serbia (Vojvodina): A four consecutive sentinel population-based survey study
Mioljub Ristić, Biljana Milosavljević, Slobodanka Vapa, et al.
PLoS ONE (2021) Vol. 16, Iss. 7, pp. e0254516-e0254516
Open Access | Times Cited: 11
A study of the evolution of the third COVID‐19 pandemic wave in the Athens metropolitan area, Greece, through two cross‐sectional seroepidemiological surveys: March, June 2021
Helena C. Maltezou, Bettina Krumbholz, Maria Mavrouli, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 4, pp. 1465-1472
Open Access | Times Cited: 11
Epidemiology of SARS-CoV-2 Infection in Italy Using Real-World Data: Methodology and Cohort Description of the Second Phase of Web-Based EPICOVID19 Study
Fulvio Adorni, Nithiya Jesuthasan, Elena Perdixi, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 3, pp. 1274-1274
Open Access | Times Cited: 7
Infection fatality rate of COVID-19 in community-dwelling populations with emphasis on the elderly: An overview
Cathrine Axfors, John P. A. Ioannidis
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 10
Seroprevalence of SARS-CoV-2 Among Workers in Northern Italy
Chiara Airoldi, Andrea Calcagno, Giovanni Di Perri, et al.
Annals of Work Exposures and Health (2021) Vol. 66, Iss. 2, pp. 224-232
Open Access | Times Cited: 9
Using an Administrative and Clinical Database to Determine the Early Spread of COVID-19 at the US Department of Veterans Affairs during the Beginning of the 2019–2020 Flu Season: A Retrospective Longitudinal Study
Lilia R. Lukowsky, Claudia Der‐Martirosian, W. Neil Steers, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 200-200
Open Access | Times Cited: 6
SARS-CoV-2 Seroprevalence Among Whole Blood Donors During First Wave of Covid-19 Pandemic in India
Srinivasa Rao Chunchu, Ushasree Ravula, Vikram Kumar Gente, et al.
Indian Journal of Hematology and Blood Transfusion (2022) Vol. 38, Iss. 3, pp. 546-555
Open Access | Times Cited: 6
Taste loss as a distinct symptom of COVID-19: A systematic review and meta-analysis
Mackenzie E. Hannum, Riley J Koch, Vicente A Ramirez, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 8
Dramatic Rise of Seroprevalence Rates of SARS-CoV-2 Antibodies among Healthy Blood Donors: The evolution of a Pandemic
Maher A. Sughayer, Asem Mansour, Abeer Al Nuirat, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 7
Precision shielding for COVID-19: metrics of assessment and feasibility of deployment
John P. A. Ioannidis
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 6
Seroprevalence of SARS-CoV-2-specific IgG antibodies in Kashmir, India, 7 months after the first reported local COVID-19 case: results of a population-based seroprevalence survey from October to November 2020
Muhammad Salim Khan, Mariya Amin Qurieshi, Inaamul Haq, et al.
BMJ Open (2021) Vol. 11, Iss. 9, pp. e053791-e053791
Open Access | Times Cited: 6
Epidemiology of SARS-CoV-2 infection in Italy using real-world data: methodology and cohort description of the second phase of web-based EPICOVID19 study
Fulvio Adorni, Nithiya Jesuthasan, Elena Perdixi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 4
A cross‐sectional study of SARS‐CoV‐2 seropositivity among healthcare workers and residents of long‐term facilities in Italy, January 2021
Valerio Bordino, Noemi Marengo, Jacopo Garlasco, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 7, pp. 3054-3062
Open Access | Times Cited: 4
Seroprevalence and characteristics of Coronavirus Disease (COVID-19) in workers with non-specific disease symptoms
Wajiha Javed, Syed Hussain Baqar Abidi, Jaffer Bin Baqar
BMC Infectious Diseases (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Systematic review of seroprevalence of SARS-CoV-2 antibodies and appraisal of evidence, prior to the widespread introduction of vaccine programmes in the WHO European Region, January–December 2020
Aisling Vaughan, Erika Duffell, Gudrun Freidl, et al.
BMJ Open (2023) Vol. 13, Iss. 11, pp. e064240-e064240
Open Access | Times Cited: 2
Whole blood derived covid convalescent plasma: An economical option among developing countries
Ushasree Ravula, Srinivasa Rao Chunchu, Vikram Kumar Gente
Transfusion and Apheresis Science (2021) Vol. 60, Iss. 2, pp. 103045-103045
Open Access | Times Cited: 5
COVID-19 immunization threshold(s): an analysis
Luis Alfredo Bautista Balbás, Mario Gil Conesa, Blanca Bautista Balbás, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 5

Scroll to top